Stockscreener 앱 받기
1.75
5.41%
-0.10
시간 외 거래:
1.75
전일 마감가:
$1.85
열려 있는:
$1.82
하루 거래량:
2,505
Relative Volume:
0.06
시가총액:
$9.54M
수익:
-
순이익/손실:
$-2.25M
주가수익비율:
-3.6765
EPS:
-0.476
순현금흐름:
-
1주 성능:
-0.28%
1개월 성능:
-16.14%
6개월 성능:
-35.02%
1년 성능:
+69.90%
1일 변동 폭
$1.71
$1.82
1주일 범위
$1.71
$1.96
52주 변동 폭
$0.76
$4.9897
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
XTLB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| XTLB | 1.75 | 9.54M | 0 | -2.25M | 0 | -0.476 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-05-08 | 개시 | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr 주식(XTLB)의 최신 뉴스
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks
A stock that deserves closer examination: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) – US Post News - US Post News
XTL Biopharmaceuticals Announces Upcoming Shareholder MeetingTipRanks.com - TipRanks
XTL Biopharmaceuticals acquires AI firm Social Proxy By Investing.com - Investing.com
XTL Biopharmaceuticals acquires AI firm Social Proxy - Investing.com India
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.TipRanks.com - TipRanks
XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewswire Inc.
Market Recap: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB)'s Positive Momentum, Closing at 2.62 – DWinneX - The Dwinnex
XTL Biopharmaceuticals Expands Portfolio Amidst Profitable QuarterTipRanks.com - TipRanks
XTL Biopharmaceuticals Regains Nasdaq ComplianceTipRanks.com - TipRanks
XTL Biopharmaceuticals Convenes Extraordinary General MeetingTipRanks.com - TipRanks
Enhance Your Investment Strategy with Altman Z-Score Screener By Investing.com - Investing.com India
XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidanc - Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial - Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
List of US Companies Releasing Earnings (EPS) Today - FX Leaders
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 T - Benzinga
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance
15 Biggest Mid-Day Gainers For ThursdayCuris (NASDAQ:CRIS), Federal Agricultural (NYSE:AGM), Canadian - Benzinga
Mid-Afternoon Market Update: Monotype Drops On Earnings Miss; LMI Aerospace Shares Spike HigherDeere ( - Benzinga
Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter - Benzinga
Morning Market LosersCentury Aluminum (NASDAQ:CENX) - Benzinga
X T L Biopharmaceuticals Ltd Adr (XTLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):